Aarti Pharmalabs Ltd approves Q2 FY27 results, with consolidated revenue of ₹610.45 crore and net profit of ₹71.47 crore
- Consolidated revenue rose 13.9% sequentially and 45.9% year on year; net profit fell 6.1% sequentially and increased 248.8% year on year.
- Results include a ₹2.04 crore exceptional provision for a stamp-duty matter; a further ₹57.46 crore was disclosed as a contingent liability. Auditors issued an unmodified review conclusion with emphasis-of-matter disclosures.
- Piyush Lakhani’s CFO departure is effective October 30; Vibha Thakkar will assume the role on October 31, 2026.